(S,E)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid, 98%, 1g

2-Fluoro-5-(trifluoromethyl)benzonitrile, 97.0%, 180g

Ethyl 3-Bromobenzoate>98.0%(GC)5g

5-Amino-2-methoxy-4-methylbenzoic acid, 98%, 100mg

2-Amino-3-fluorobenzamide, 95.0%, 10g

(4-Bromo-1-fluoronaphthalen-2-yl)boronic acid, 95.0%, 5g

3-(3-methoxypropyl)piperidine, 95.0%, 10g

2-Methoxy-N-[(piperidin-4-yl)methyl]pyridin-4-amine dihydrochloride, 1g

4-Bromo-6-chloro-1H-indazole, 95.0%, 10g

Paxilline, 99.70%, 5mg

Noir bleu d'ériochrome R (CI 15705), pour complexométrie, 5 g, conditionnement en verre

3-hydroxy-1',2'-dihydrospiro[cyclobutane-1,3'-pyrrolo[2,3-b]pyridine]-2'-one, 95.0%, 250mg

tert-Butyl 6-amino-1H-benzo[d]imidazole-1-carboxylate, 96%, 100mg